Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06946160

Completed

A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines

Glabellar Frown Lines | Glabellar Lines
NCT05801146

Recruiting

Evaluate the Safety and Efficacy of HG102 as Compared to Botox® in Subject With Moderate to Severe Glabellar Lines

Glabellar Lines
NCT07321834

Active, not recruiting

A Study to Evaluate AI-09 In Participants With Glabellar Lines

Glabellar Lines
NCT05100199

Completed

A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines

Glabellar Lines
NCT05089357

Completed

Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin

Glabellar Lines
NCT06308198

Completed

A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines

Glabellar Lines
NCT05248867

Completed

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines

Glabellar Lines
NCT04096326

Completed

AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

Glabellar Lines
NCT05298449

Completed

Phase 2 of HU-045 in Glabellar Lines

Glabellar Lines
NCT02493946

Completed

Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines

Glabellar Lines
NCT05531968

Completed

Treatment of Moderate to Severe Glabellar Lines (BMI2006) (BMI2006)

Glabellar Lines
NCT02353897

Completed

Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport® (APPEAL)

Glabellar Lines
NCT00752258

Completed

A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows (PT-03c)

Glabellar Rhytides
NCT05248880

Completed

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines

Glabellar Lines
NCT06834789

Completed

A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)

Glabellar Lines
NCT06212960

Completed

Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines

Glabellar Lines
NCT03795922

Completed

MT10109L in the Treatment of Glabellar Lines

Glabellar Lines
NCT05292638

Completed

Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines

Glabellar Lines
NCT02450526

Completed

Dysport in the Treatment of Glabellar Lines in Chinese Subjects

Glabellar Lines
NCT00856999

Completed

Botox Cosmetic and the Young Patient With Glabellar Furrows

Glabellar Furrows
NCT01271452

Completed

Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines

Glabellar Lines
NCT02961673

Completed

The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Glabellar Lines
NCT00408785

Completed

A Study Of BOTOX For The Treatment Of Glabellar Lines

Glabellar Lines
NCT00611273

Completed

A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing

Glabellar Furrowing
NCT06124794

Completed

The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines
NCT05364580

Completed

The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines
NCT05217355

Completed

A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines
NCT01333397

Completed

Safety and Efficacy Study of Dysport RU and Glabellar Lines

Glabellar Frown Lines
NCT03014635

Completed

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Glabellar Frown Lines
NCT04143815

Completed

Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines

Glabellar Frown Lines
NCT04281095

Completed

A Comparative Study of Botulinum Neurotoxin Type A in Treatment of Moderate to Severe Glabellar Frown Lines

Glabellar Frown Lines
NCT02428608

Completed

Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006 (EV-006)

Glabellar Frown Lines
NCT02184988

Completed

Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines (EV-004)

Glabellar Frown Lines
NCT02334436

Completed

A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002 (EV-002)

Glabellar Frown Lines
NCT02334423

Completed

A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001

Glabellar Frown Lines
NCT02303002

Completed

Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines

Glabellar Frown Lines
NCT01391312

Completed

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Glabellar Frown Lines
NCT00777803

Completed

NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines (Head2Head)

Glabellar Frown Lines
NCT05623410

Recruiting

Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moderate to Severe Glabellar Frown Lines

Glabellar Frown Lines
NCT06411002

Completed

Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines

Glabellar Frown Lines
NCT05146999

Completed

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines
NCT01485601

Completed

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Glabellar Frown Lines
NCT02236312

Completed

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Glabellar Frown Lines
NCT03687736

Completed

Subject Satisfaction With AbobutulinumtoxinA Treatment (DREAM)

Glabellar Frown Lines
NCT03014622

Completed

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Glabellar Frown Lines
NCT03004248

Completed

Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines

Glabellar Frown Lines
NCT05059587

Completed

Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines

Glabellar Frown Lines
NCT04996810

Completed

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines
NCT03289169

Completed

Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines

Glabellar Frown Lines
NCT03837561

Completed

The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations